Nasha Qiu

3.5k total citations · 2 hit papers
38 papers, 2.6k citations indexed

About

Nasha Qiu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Nasha Qiu has authored 38 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Biomedical Engineering and 9 papers in Biomaterials. Recurrent topics in Nasha Qiu's work include RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Virus-based gene therapy research (9 papers). Nasha Qiu is often cited by papers focused on RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Virus-based gene therapy research (9 papers). Nasha Qiu collaborates with scholars based in China, United States and New Zealand. Nasha Qiu's co-authors include Youqing Shen, Zhuxian Zhou, Qihang Sun, Ying Piao, Xiangrui Liu, Jianbin Tang, Xuefei Zhou, Quan Zhou, Dingcheng Zhu and Zhen Zhang and has published in prestigious journals such as Chemical Reviews, Advanced Materials and Nature Communications.

In The Last Decade

Nasha Qiu

36 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

2017 922 citations Zhuxian Zhou, Nasha Qiu et al. Advanced Materials profile →
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration

2017 332 citations Zhuxian Zhou, Xiangrui Liu et al. Advanced Drug Delivery Reviews profile →

Peers

Nasha Qiu

BIOMA

IMMUN

Ying Piao China

Zhiting Cao China

Cao Xie China

Federico Perche France

Mikyung Yu United States

Lingjing Xue China

Wanyi Tai United States

Yao‐Xin Lin China

Cong‐Fei Xu China

Xing Guo China

Ying Piao China

Nasha Qiu

1.7k ×1.3

1.3k ×1.1

1.4k ×1.3

BIOMA

328 ×0.9

IMMUN

504 ×1.5

Citations per year, relative to Nasha Qiu Nasha Qiu (= 1×) peers Ying Piao

Countries citing papers authored by Nasha Qiu

Since Specialization

Citations

This map shows the geographic impact of Nasha Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasha Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasha Qiu more than expected).

Fields of papers citing papers by Nasha Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasha Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasha Qiu. The network helps show where Nasha Qiu may publish in the future.

Co-authorship network of co-authors of Nasha Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Nasha Qiu. A scholar is included among the top collaborators of Nasha Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasha Qiu. Nasha Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Haitao, Yujie Zhou, Hui Zhang, et al.. (2025). One-step engineered mesenchymal stem cell-derived exosomes against hepatic ischemia–reperfusion injury. International Journal of Pharmaceutics. 672. 125292–125292. 3 indexed citations

Zhu, Haoru, Chang Xu, Yu Geng, Youqing Shen, & Nasha Qiu. (2025). Endoplasmic Reticulum-Targeted Polymer-Manganese Nanocomplexes for Tumor Immunotherapy. ACS Nano. 19(4). 4959–4972. 6 indexed citations

Shen, Yidan, Yanpeng Liu, Siyu Chen, et al.. (2025). Highly permeable and tumor-selective killing Doxil for efficient cancer therapy. Nano Research. 18(12). 94907987–94907987.

Wang, Kai, Zhoucheng Wang, Xin Shao, et al.. (2025). Natural killer cell-derived granzyme B as a therapeutic target for alleviating graft injury during liver transplantation. Acta Pharmaceutica Sinica B. 15(10). 5277–5293.

Qiu, Nasha, Chang Xu, Zhen Zhang, et al.. (2025). Autologous tumoral esterase-driven therapeutic polymers sequentially orchestrated antigen-induction, STING activation and anti-angiogenesis for systemic cancer immune therapy. Biomaterials. 320. 123260–123260. 1 indexed citations

Zhang, Hui, Jianguo Wang, Xiaonan Xiang, et al.. (2024). An Esterase-Responsive SLC7A11 shRNA Delivery System Induced Ferroptosis and Suppressed Hepatocellular Carcinoma Progression. Pharmaceutics. 16(2). 249–249. 5 indexed citations

Liu, Yanpeng, Siyu Chen, Yidan Shen, et al.. (2024). Rapamycin-loaded nanoparticles elicit local liver immunosuppressive and remote anti-tumor efficacy. Nano Today. 61. 102589–102589. 3 indexed citations

Chen, Siyu, Yanpeng Liu, Haitao Hu, et al.. (2024). Mitochondria-Targeted Icaritin Nanoparticles Induce Immunogenic Cell Death in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 17(2). 2899–2910. 15 indexed citations

Wang, Shuai, Jianguo Wang, Yiyuan Chen, et al.. (2023). BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy. Cancer Letters. 571. 216336–216336. 12 indexed citations

10.

Zhang, Runnan, Shiqun Shao, Ying Piao, et al.. (2023). Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection. Advanced Materials. 35(46). e2303614–e2303614. 46 indexed citations

11.

Wei, Xuyong, et al.. (2023). Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases. International Journal of Nanomedicine. Volume 18. 2873–2890. 28 indexed citations

12.

Wu, Yichao, Abid Khan, Kangchen Chen, et al.. (2023). Insulin-induced gene 2 protects against hepatic ischemia–reperfusion injury via metabolic remodeling. Journal of Translational Medicine. 21(1). 739–739. 4 indexed citations

13.

Liu, Jing, Zhihao Zhao, Nasha Qiu, et al.. (2021). Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy. Nature Communications. 12(1). 2425–2425. 123 indexed citations

14.

Zhou, Quan, Chengyuan Dong, Wufa Fan, et al.. (2020). Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy. Biomaterials. 240. 119902–119902. 186 indexed citations

15.

Liu, Yun, Nasha Qiu, Limei Shen, et al.. (2020). Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. Journal of Controlled Release. 323. 431–441. 49 indexed citations

16.

Qiu, Nasha, Yun Liu, Qi Liu, et al.. (2020). Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 269. 120604–120604. 77 indexed citations

17.

Qiu, Nasha, Guowei Wang, Quan Zhou, et al.. (2020). Tumor‐Associated Macrophage and Tumor‐Cell Dually Transfecting Polyplexes for Efficient Interleukin‐12 Cancer Gene Therapy. Advanced Materials. 33(2). e2006189–e2006189. 92 indexed citations

18.

Zhou, Zhuxian, Xiangrui Liu, Dingcheng Zhu, et al.. (2017). Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration. Advanced Drug Delivery Reviews. 115. 115–154. 332 indexed citations breakdown →

19.

Zhou, Xuefei, Xiangrui Liu, Bingxiang Zhao, et al.. (2016). Jumping the nuclear envelope barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306. Journal of Controlled Release. 234. 90–97. 12 indexed citations

20.

Qiu, Nasha, Xiangrui Liu, Meihua Sui, Jianbin Tang, & Youqing Shen. (2015). Paclitaxel improved gene transfection efficiency through cell synchronization in SW480 cells. Journal of Controlled Release. 213. e83–e83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact